Investigating Thirst Dimensions in Heart Failure Patients Using the Theory of Unpleasant Symptoms: A Cross-Sectional Study"
Thirst Dimensions in Heart Failure Patients
,
Abstract
Abstract
Background: Vasoconstriction in the salivary glands, changes in the sympathetic nervous system, fluid restriction, nursing care services, together with pharmacotherapy in heart failure (HF) patients cause thirst as a painful complication. Against this background, the present study aimed to reflect on thirst dimensions based on the theory of unpleasant symptoms (ToUS) in HF patients.
Methods: This descriptive cross-sectional study was fulfilled on 217 HF patients, admitted to the teaching hospitals in the city of Tehran, Iran, from May to November, 2020, who were selected based on purposive sampling and upon meeting some inclusion criteria. The data collection tools consisted of the demographic survey form (DSF), the Thirst Intensity Visual Analogue Scale (TI-VAS), the Thirst Frequency Scale (TFS), and the Thirst Distress Scale (TDS). The data were then analyzed by descriptive and analytical statistics using the SPSS (ver. 20) software package.
Results: The standard deviation (SD) scores of thirst intensity in the HF patients were 47.53±26.37 (viz. at the moderate level) and such values for thirst distress were equal to 25.92±8.13 (i.e., at the high level). Most patients (35.9%) also had high degrees of thirst distress. In addition, the majority had felt thirsty over the last month, almost every day (61%), which had occurred all day long. The level of education, HF class, living conditions, fluid restriction, taking angiotensin-converting enzyme (ACE) inhibitors, beta-blockers, aldosterone antagonists or diuretics, as well as suffering from diabetes were ultimately identified as the main predictors of thirst intensity and distress.
Conclusion: With regard to the high prevalence rate of thirst in HF patients and the bothersomeness of this condition, nurses are suggested to consider thirst sensation while they deliver care services to these individuals, and then shed light on the effective factors and predict thirst intensity during history-taking.
2. Rossignol P, Hernandez AF, Solomon SD, Zannad F. Heart failure drug treatment. The Lancet. 2019;393(10175):1034-1044.
3. Felker GM, Mann DL. Heart Failure E-Book: A Companion to Braunwald's Heart Disease. Elsevier Health Sciences; 2014.
4. Ifrim M, Bontaş E, Cochior D, Ţintoiu IC. Right Heart Anatomy: A Short Uptodate. Right Heart Pathology: From Mechanism to Management. 2018:25-56.
5. Shofany C. Quality of life among chronic disease patients. Nursing & Care Open Access Journal. 2017;4(2):385-94.
6. Bonow RO, Mann DL, Zipes DP, Libby P. Braunwald's heart disease e-book: A textbook of cardiovascular medicine. Elsevier Health Sciences; 2011.
7. Dassanayaka S, Jones SP. Recent developments in heart failure. Circulation research. 2015;117(7):e58-e63.
8. Eisen H. Heart failure: a comprehensive guide to pathophysiology and clinical care. springer; 2017.
9. McDonagh TA, Metra M, Adamo M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC. European heart journal. 2021;42(36):3599-3726.
10. Palazzuoli A, Gallotta M, Quatrini I, Nuti R. Natriuretic peptides (BNP and NT-proBNP): measurement and relevance in heart failure. Vascular health and risk management. 2010;6:411.
11. Ahmadi A, Soori H, Mobasheri M, Etemad K, Khaledifar A. Heart failure, the outcomes, predictive and related factors in Iran. Journal of Mazandaran University of Medical Sciences. 2014;24(118):180-188.
12. Benjamin EJ, Muntner P, Alonso A, et al. Heart disease and stroke statistics—2019 update: a report from the American Heart Association. Circulation. 2019;139(10):e56-e528.
13. Dunlay SM, Roger VL. Understanding the epidemic of heart failure: past, present, and future. Current heart failure reports. 2014;11:404-415.
14. Rotunno R, Oppo I, Saetta G, Aveta P, Bruno S. NSAIDs and heart failure: A dangerous relationship. Monaldi Archives for Chest Disease. 2018;88(2)
15. Desai AS, Stevenson LW. Rehospitalization for heart failure: predict or prevent? Circulation. 2012;126(4):501-506.
16. Bader F, Manla Y, Atallah B, Starling RC. Heart failure and COVID-19. Heart failure reviews. 2021;26(1):1-10.
17. Comín-Colet J, Anguita M, Formiga F, et al. Health-related quality of life of patients with chronic systolic heart failure in Spain: results of the VIDA-IC study. Revista Española de Cardiología (English Edition). 2016;69(3):256-271.
18. Waldreus N, Jaarsma T, van der Wal MH, Kato NP. Development and psychometric evaluation of the Thirst Distress Scale for patients with heart failure. European Journal of Cardiovascular Nursing. 2018;17(3):226-234.
19. Eng SH, Waldréus N, González B, et al. Thirst distress in outpatients with heart failure in a Mediterranean zone of Spain. ESC heart failure. 2021;8(4):2492-2501.
20. van der Wal MH, Waldréus N, Jaarsma T, Kato NP. Thirst in patients with heart failure in Sweden, the Netherlands, and Japan. Journal of Cardiovascular Nursing. 2020;35(1):19-25.
21. Waldreus N, Chung ML, van der Wal MH, Jaarsma T. Trajectory of thirst intensity and distress from admission to 4-weeks follow up at home in patients with heart failure. Patient preference and adherence. 2018:2223-2231.
22. Eng SH, Jaarsma T, Lupón J, et al. Thirst and factors associated with frequent thirst in patients with heart failure in Spain. Heart & Lung. 2021;50(1):86-91.
23. Negro A, Villa G, Greco M, et al. Thirst in patients admitted to intensive care units: an observational study. Irish Journal of Medical Science (1971-). 2021:1-7.
24. Pierotti I, Fracarolli IFL, Fonseca LF, Aroni P. Evaluation of the intensity and discomfort of perioperative thirst. Escola Anna Nery. 2018;22
25. Wefer F, Inkrot S, Waldréus N, Jaarsma T, von Cube M, Kugler C. Translation and Psychometric Evaluation of the German Version of the Thirst Distress Scale for Patients With Heart Failure. Journal of Cardiovascular Nursing. 2022;37(4):378-385.
26. Kara B. Determinants of thirst distress in patients on hemodialysis. International urology and nephrology. 2016;48:1525-1532.
27. Porcu M, Fanton E, Zampieron A. Thirst distress and interdialytic weight gain: a study on a sample of haemodialysis patients. Journal of renal care. 2007;33(4):179-181.
28. Schooling CM, Jones HE. Clarifying questions about “risk factors”: predictors versus explanation. Emerging themes in epidemiology. 2018;15(1):1-6.
| Files | ||
| Issue | Vol 19 No S1 (2024): Supplementary 1 | |
| Section | Original Article(s) | |
| DOI | https://doi.org/10.18502/jthc.v19is1.18473 | |
| Keywords | ||
| Thirst Heart Failure Theory of Unpleasant Symptoms patient | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
